Innovedge Research Private Limited is a forward-thinking, science-driven CRO dedicated to accelerating healthcare innovation through high-quality clinical trials and strategic scientific and regulatory consulting.
We partner with pharmaceutical, biotechnology, medical device, and HealthTech companies to bring safe and effective therapies to market efficiently and compliantly.
From early-stage development to late-phase clinical trials and regulatory submissions, we deliver scientifically robust, regulatorily aligned, and operationally efficient solutions, fully compliant with global standards including ICH-GCP, FDA, EMA, and CDSCO.
Innovedge is more than a CRO, we are a strategic development partner, integrating science, regulation, and execution to navigate complexity and accelerate success across the product lifecycle.
Delivering Excellence Through Smart Solutions
Innovedge Research helps emerging sponsors overcome early-stage clinical development barriers through an agile, science-driven approach. We deliver end-to-end clinical and consulting solutions designed to accelerate development and ensure high-quality outcomes across the full lifecycle from early strategy and study design to clinical trial execution and post-marketing evidence generation.
Our capabilities span Phase I–IV clinical trial design and management, scientific and regulatory strategy, and global regulatory support across key markets including FDA, EMA, and CDSCO. We also offer specialized expertise in 505(b)(2) development pathways to enable faster and more cost-effective advancement, along with real-world evidence generation through observational studies, registries, and post-marketing research.
By integrating cross-functional expertise with strong project management and quality systems, we simplify complexity, ensure compliance, and deliver reliable, decision ready data helping sponsors accelerate timelines and confidently advance their programs.
Contact us to learn how our team can help!
